|
1
|
Calvert JW and Zhang JH: Pathophysiology
of an hypoxic-ischemic insult during the perinatal period. Neurol
Res. 27:246–260. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Khot S and Tirschwell DL: Long-term
neurological complications after hypoxic-ischemic encephalopathy.
Semin Neurol. 26:422–431. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kristián T: Metabolic stages, mitochondria
and calcium in hypoxic/ischemic brain damage. Cell Calcium.
36:221–233. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bi Y, Gong M, Zhang X, Zhang X, Jiang W,
Zhang Y, Chen J, Liu Y, He TC and Li T: Pre-activation of retinoid
signaling facilitates neuronal differentiation of mesenchymal stem
cells. Dev Growth Differ. 52:419–431. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu Y, Zhang X, Dai Y, Shu C, Qu P, Liu
YX, Yang L and Li TY: Effects of bone marrow mesenchymal stem cells
on learning and memory functional recovery in neonatal rats with
hypoxic-ischemic brain damage. Zhonghua Er Ke Za Zhi. 46:648–653.
2008.In Chinese. PubMed/NCBI
|
|
6
|
Phinney DG and Isakova I: Plasticity and
therapeutic potential of mesenchymal stem cells in the nervous
system. Curr Pharm Des. 11:1255–1265. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang Y, Yang Y, Bi Y, Gong M, Jiang W,
Wei X, Li T and Chen J: Mesenchymal stromal cell neuroprotection of
hydrogen peroxide-challenged pheochromocytoma cells through
reducing apoptosis and releasing cytokines. Cytotherapy.
14:954–966. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Winter CD, Pringle AK, Clough GF and
Church MK: Raised paren-chymal interleukin-6 levels correlate with
improved outcome after traumatic brain injury. Brain. 127:315–320.
2004. View Article : Google Scholar
|
|
9
|
Hüll M, Strauss S, Berger M, Volk B and
Bauer J: The participation of interleukin-6, a stress-inducible
cytokine, in the pathogenesis of Alzheimer's disease. Behav Brain
Res. 78:37–41. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Qiu Z, Sweeney DD, Netzeband JG and Gruol
DL: Chronic interleukin-6 alters NMDA receptor-mediated membrane
responses and enhances neurotoxicity in developing CNS neurons. J
Neurosci. 18:10445–10456. 1998.PubMed/NCBI
|
|
11
|
Erta M, Quintana A and Hidalgo J:
Interleukin-6, a major cytokine in the central nervous system. Int
J Biol Sci. 8:1254–1266. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen J, Ng CP, Rowlands DK, Xu PH, Gao JY,
Chung YW and Chan HC: Interaction between enteric epithelial cells
and Peyer's patch lymphocytes in response to Shigella
lipopolysaccharide: Effect on nitric oxide and IL-6 release. World
J Gastroenterol. 12:3895–3900. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang Y, Gong M, Bi Y, Jiang W, Yu Q, Li
TY and Chen J: Construction and identification of recombinant
adenovirus vector containing siRNA of rat TLR2 gene. Xi Bao Yu Fen
Zi Mian Yi Xue Za Zhi. 28:144–147. 2012.In Chinese. PubMed/NCBI
|
|
14
|
Liu JJ, Zhang YJ, Bi Y, Gong M, Li T-y and
Chen J: Construction and preliminary identification of rat
interleukin-6 recombinant adenovirus. Immunol J. 30:151–155.
2014.
|
|
15
|
He M-l, Liu J-j, Gu Y, L T-y and Chen J:
Effects of inhibiting secretion of mesenchymal stem cells
originated interleukin-6 on oxygen glucose deprivation injured PC12
cells. J Shanghai Jiaotong Uni (Sci). 34:1435–1447. 2014.
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
17
|
Gong M, Bi Y, Jiang W, Zhang Y, Chen L,
Hou N, Liu Y, Wei X, Chen J and Li T: Immortalized mesenchymal stem
cells: An alternative to primary mesenchymal stem cells in neuronal
differentiation and neuroregeneration associated studies. J Biomed
Sci. 18:872011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kishimoto T: Interleukin-6: Discovery of a
pleiotropic cytokine. Arthritis Res Ther. 8(Suppl 2): S22006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kishimoto T: IL-6: From its discovery to
clinical applications. Int Immunol. 22:347–352. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Woodcock T and Morganti-Kossmann MC: The
role of markers of inflammation in traumatic brain injury. Front
Neurol. 4:182013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Arroyo DS, Soria JA, Gaviglio EA,
Rodriguez-Galan MC and Iribarren P: Toll-like receptors are key
players in neurodegeneration. Int Immunopharmacol. 11:1415–1421.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang YC, Lin S and Yang QW: Toll-like
receptors in cerebral ischemic inflammatory injury. J
Neuroinflammation. 8:1342011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vogel SN, Fitzgerald KA and Fenton MJ:
TLRs: Differential adapter utilization by toll-like receptors
mediates TLR-specific patterns of gene expression. Mol Interv.
3:466–477. 2003. View Article : Google Scholar
|
|
24
|
Marsh BJ, Williams-Karnesky RL and
Stenzel-Poore MP: Toll-like receptor signaling in endogenous
neuroprotection and stroke. Neuroscience. 158:1007–1020. 2009.
View Article : Google Scholar :
|
|
25
|
Crack PJ and Bray PJ: Toll-like receptors
in the brain and their potential roles in neuropathology. Immunol
Cell Biol. 85:476–480. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mohamed MR and McFadden G: NFκB
inhibitors: Strategies from poxviruses. Cell Cycle. 8:3125–3132.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Takeda K and Akira S: Toll-like receptors
in innate immunity. Int Immunol. 17:1–14. 2005. View Article : Google Scholar
|
|
28
|
Akhmatova NK, Egorova NB, Kurbatova EA and
Akhmatov EA: Activation of innate immunity by bacterial ligands of
toll-like receptors. Front Immunol. 5:892014. View Article : Google Scholar : PubMed/NCBI
|
